Deján Dobi

692 total citations
16 papers, 142 citations indexed

About

Deján Dobi is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Transplantation. According to data from OpenAlex, Deján Dobi has authored 16 papers receiving a total of 142 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nephrology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Transplantation. Recurrent topics in Deján Dobi's work include Renal Transplantation Outcomes and Treatments (6 papers), Renal Diseases and Glomerulopathies (6 papers) and Vasculitis and related conditions (4 papers). Deján Dobi is often cited by papers focused on Renal Transplantation Outcomes and Treatments (6 papers), Renal Diseases and Glomerulopathies (6 papers) and Vasculitis and related conditions (4 papers). Deján Dobi collaborates with scholars based in Hungary, United States and Italy. Deján Dobi's co-authors include Zoltán Lászik, Flavio Vincenti, Minnie Sarwal, Tara K. Sigdel, Juliane Liberto, Gábor Lotz, Zsuzsa Schaff, András Kiss, István Vályi‐Nagy and Tibor Várkonyi and has published in prestigious journals such as Scientific Reports, Transplantation and Journal of Histochemistry & Cytochemistry.

In The Last Decade

Deján Dobi

13 papers receiving 142 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deján Dobi Hungary 7 40 38 36 34 30 16 142
Ronaldo de Matos Esmeraldo Brazil 7 54 1.4× 58 1.5× 54 1.5× 16 0.5× 32 1.1× 20 226
Simon Ville France 8 77 1.9× 33 0.9× 32 0.9× 19 0.6× 39 1.3× 25 191
Jakob Thaning Bay Denmark 9 38 0.9× 13 0.3× 68 1.9× 40 1.2× 24 0.8× 18 217
Susan Hartzell United States 7 19 0.5× 12 0.3× 83 2.3× 26 0.8× 20 0.7× 14 190
Hamza Sakhi France 7 9 0.2× 12 0.3× 65 1.8× 42 1.2× 9 0.3× 16 151
Andrea Solazzo Italy 6 33 0.8× 21 0.6× 19 0.5× 22 0.6× 15 0.5× 11 147
Marta Suñer Spain 6 56 1.4× 25 0.7× 11 0.3× 56 1.6× 31 1.0× 8 130
Caridad Martinez United States 7 27 0.7× 7 0.2× 23 0.6× 21 0.6× 32 1.1× 15 150
J.‐F. Subra France 5 9 0.2× 24 0.6× 25 0.7× 7 0.2× 23 0.8× 7 130
Naonori Harada Japan 9 18 0.5× 14 0.4× 15 0.4× 12 0.4× 44 1.5× 37 227

Countries citing papers authored by Deján Dobi

Since Specialization
Citations

This map shows the geographic impact of Deján Dobi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deján Dobi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deján Dobi more than expected).

Fields of papers citing papers by Deján Dobi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deján Dobi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deján Dobi. The network helps show where Deján Dobi may publish in the future.

Co-authorship network of co-authors of Deján Dobi

This figure shows the co-authorship network connecting the top 25 collaborators of Deján Dobi. A scholar is included among the top collaborators of Deján Dobi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deján Dobi. Deján Dobi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Dobi, Deján, et al.. (2025). Unexpected renal side effects of mRNA COVID-19 vaccines; a single-center experience and short review. The American Journal of the Medical Sciences. 369(6). 739–744.
2.
Ciobanu, D. C., Valeria Tomati, Deján Dobi, et al.. (2024). WS14.02 Tezacaftor is a direct inhibitor of sphingolipid delta-4 desaturase enzyme (DEGS). Journal of Cystic Fibrosis. 23. S26–S26.
3.
Somorácz, Áron, et al.. (2023). Renal Cell Carcinoma in End-Stage Renal Disease: A Retrospective Study in Patients from Hungary. Pathobiology. 90(5). 322–332. 2 indexed citations
4.
Tislér, András, et al.. (2022). A unique case of anti-GBM disease with concomitant anti-PLA2R positivity. BMC Nephrology. 23(1). 337–337. 2 indexed citations
5.
Glasz, Tibor, Tibor Várkonyi, Tamás Barbai, et al.. (2022). Liver alterations and detection of SARS-CoV-2 RNA and proteins in COVID-19 autopsies. GeroScience. 45(2). 1015–1031. 18 indexed citations
6.
Törő, Klára, János Szlávik, Botond Lakatos, et al.. (2021). A COVID-19-association-dependent categorization of death causes in 100 autopsy cases. GeroScience. 43(5). 2265–2287. 19 indexed citations
7.
Fintha, Attila, et al.. (2021). Kidney biopsy-based epidemiologic analysis shows growing biopsy rate among the elderly. Scientific Reports. 11(1). 24479–24479. 11 indexed citations
8.
9.
Dobi, Deján, et al.. (2020). Novel In Situ Hybridization and Multiplex Immunofluorescence Technology Combined With Whole-slide Digital Image Analysis in Kidney Transplantation. Journal of Histochemistry & Cytochemistry. 68(7). 445–459. 6 indexed citations
10.
Sigdel, Tara K., Juliane Liberto, Deján Dobi, et al.. (2019). Assessment of 19 Genes and Validation of CRM Gene Panel for Quantitative Transcriptional Analysis of Molecular Rejection and Inflammation in Archival Kidney Transplant Biopsies. Frontiers in Medicine. 6. 213–213. 20 indexed citations
11.
Abraham, Vivek C., Loan Miller, Zoltán Lászik, et al.. (2019). Further Evidence That the Soluble Urokinase Plasminogen Activator Receptor Does Not Directly Injure Mice or Human Podocytes. Transplantation. 104(1). 54–60. 19 indexed citations
12.
Sigdel, Tara K., Deján Dobi, Szu‐Chuan Hsieh, et al.. (2018). Targeted Transcriptional Profiling of Kidney Transplant Biopsies. Kidney International Reports. 3(3). 722–731. 18 indexed citations
13.
Vasquez, Joshua, Rajaa Hussien, Deján Dobi, et al.. (2018). Elucidating the Burden of HIV in Tissues Using Multiplexed Immunofluorescence and In Situ Hybridization: Methods for the Single-Cell Phenotypic Characterization of Cells Harboring HIV In Situ. Journal of Histochemistry & Cytochemistry. 66(6). 427–446. 18 indexed citations
14.
15.
Dobi, Deján, Éva Kemény, P. Szenohradszky, et al.. (2016). Peritubular capillary basement membrane multilayering in early and advanced transplant glomerulopathy: quantitative parameters and diagnostic aspects. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 469(5). 563–573. 4 indexed citations
16.
Dobi, Deján, Éva Kemény, Krisztina Boda, et al.. (2015). Morphologic Features and Clinical Impact of Arteritis Concurrent with Transplant Glomerulopathy. Pathology & Oncology Research. 22(1). 15–25. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ronaldo de Matos Esmeraldo Breakdown of academic impact, for papers by Simon Ville Breakdown of academic impact, for papers by Jakob Thaning Bay Breakdown of academic impact, for papers by Susan Hartzell Breakdown of academic impact, for papers by Hamza Sakhi Breakdown of academic impact, for papers by Andrea Solazzo Breakdown of academic impact, for papers by Marta Suñer Breakdown of academic impact, for papers by Caridad Martinez Breakdown of academic impact, for papers by J.‐F. Subra Breakdown of academic impact, for papers by Naonori Harada
Rankless by CCL
2026